Market Access
What India can learn from Kinvard Bio
India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.
Market Access
The new commercialisation playbook: What BIO 2026 taught eme...
BIO International focused on how emerging biotech companies should approach their first product launch outside the United States, typically in Europe.
News
MHRA clarifies UK position on microbiome-based medicines
The MHRA has published its position paper clarifying how microbiome-based medicines can be made available for patients in the UK.
News
Pfizer, Valneva Lyme vaccine starts review in Europe
After reporting mixed clinical results in a phase 3 trial, Pfizer and Valneva have filed their Lyme disease vaccine candidate PF-07307405 in the EU.
News
BMS bags first approval for myeloma CELMoD Zenbexus
Bristol Myers Squibb's CELMoD pipeline has delivered its first approval, for iberdomide, as part of a combination regimen for multiple myeloma.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
